Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
A clear picture of the cost and efficacy of COVID-19 outpatient treatments
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...
Cardiovascular care following a heart attack influenced by unemployment—and more so in the US than Canada, study suggests
New RI-MUHC study shows that health systems and unemployment influence...
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
Multiplexed technologies are paving the way to rapid and equitable screening for sexually transmitted infections
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...
RI-MUHC researchers are successful co-leaders in “100 years of insulin” funding call
Pan-Canadian team receives financing to develop a national pediatric diabetes registry
Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States
Recruitment of first U.S.-based patients in dapsone trial has started
The Canadian Longitudinal Study on Aging targets brain health
Thanks to the Weston Family Foundation, the CLSA will employ MRI imaging and microbiome analyses to investigate cognitive aging
Research on dysanapsis recognized by McGill Medstar Award for Trainees
Congratulations to RI-MUHC trainee Motahareh Vameghestahbanati!
Can inhaled corticosteroids alleviate early symptoms of COVID-19?
Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo